Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06821750 · ClinicalTrials.gov registry record · Phase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults
A Phase 1 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT06821750 is a Phase 1 study that was terminated before completion, run by Pfizer. The registered enrollment target is 23 participants.
The verdict
NCT06821750, a Phase 1 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to learn if the study medicine (called PF-07314470) is safe and how it gets in and out of the body in healthy people.
Interventions
- BIOLOGICAL PF-07314470
- BIOLOGICAL Placebo for PF-07314470
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2025-08-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06821750
The ClinicalTrials.gov registry entry for NCT06821750 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PF-07314470 is the first listed.
NCT06821750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06821750 about?
NCT06821750 is a clinical study titled "A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults". The purpose of this clinical trial is to learn if the study medicine (called PF-07314470) is safe and how it gets in and out of the body in healthy people.
What is the current status of trial NCT06821750?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2025-02-11. Estimated completion is 2025-08-18.
What interventions are being tested in trial NCT06821750?
The interventions under investigation include: PF-07314470 (BIOLOGICAL), Placebo for PF-07314470 (BIOLOGICAL).
Who is sponsoring clinical trial NCT06821750?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.